These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27457212)

  • 1. Metabolomic Insight into Lipid and Protein Profile in Diabetes Using Mass Spectrometry.
    Bukowiecka-Matusiak M; Chmielewska-Kassassir M; Szczesna D; Wozniak LA
    Mini Rev Med Chem; 2016; 16(14):1167-74. PubMed ID: 27457212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass spectrometry: from proteomics to metabolomics and lipidomics.
    Griffiths WJ; Wang Y
    Chem Soc Rev; 2009 Jul; 38(7):1882-96. PubMed ID: 19551169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical evaluation of peak capacity improvements by use of liquid chromatography combined with drift tube ion mobility-mass spectrometry.
    Causon TJ; Hann S
    J Chromatogr A; 2015 Oct; 1416():47-56. PubMed ID: 26372446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small intestine proteomics coupled with serum metabolomics reveal disruption of amino acid metabolism in Chinese hamsters with type 2 diabetes mellitus.
    Wang C; Yu J; Zhang R; Wang W; Shi Z; Liu Y; Song G; Wang H; Han N; Huang L; An Y; Tian S; Chen Z
    J Proteomics; 2020 Jul; 223():103823. PubMed ID: 32428569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct infusion mass spectrometry for metabolomic phenotyping of diseases.
    González-Domínguez R; Sayago A; Fernández-Recamales Á
    Bioanalysis; 2017 Jan; 9(1):131-148. PubMed ID: 27921460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advanced Mass Spectrometry-Based Biomarker Identification for Metabolomics of Diabetes Mellitus and Its Complications.
    Zhang F; Shan S; Fu C; Guo S; Liu C; Wang S
    Molecules; 2024 May; 29(11):. PubMed ID: 38893405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolomic Strategies Involving Mass Spectrometry Combined with Liquid and Gas Chromatography.
    Lopes AS; Cruz EC; Sussulini A; Klassen A
    Adv Exp Med Biol; 2017; 965():77-98. PubMed ID: 28132177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances of chromatography and mass spectrometry in lipidomics.
    Li M; Zhou Z; Nie H; Bai Y; Liu H
    Anal Bioanal Chem; 2011 Jan; 399(1):243-9. PubMed ID: 21052649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics and lipidomics using traveling-wave ion mobility mass spectrometry.
    Paglia G; Astarita G
    Nat Protoc; 2017 Apr; 12(4):797-813. PubMed ID: 28301461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UPLC-MS(E) application in disease biomarker discovery: the discoveries in proteomics to metabolomics.
    Zhao YY; Lin RC
    Chem Biol Interact; 2014 May; 215():7-16. PubMed ID: 24631021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics, metabolomics and metagenomics for type 2 diabetes and its complications.
    Wang N; Zhu F; Chen L; Chen K
    Life Sci; 2018 Nov; 212():194-202. PubMed ID: 30243649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic investigation of human diseases biomarkers by CE and LC coupled to MS.
    Buzatto AZ; de Sousa AC; Guedes SF; Cieslarová Z; Simionato AV
    Electrophoresis; 2014 May; 35(9):1285-307. PubMed ID: 24375663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Key elements of metabolomics in the study of biomarkers of diabetes.
    Adamski J
    Diabetologia; 2016 Dec; 59(12):2497-2502. PubMed ID: 27714446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyphenated MS-based targeted approaches in metabolomics.
    Begou O; Gika HG; Wilson ID; Theodoridis G
    Analyst; 2017 Aug; 142(17):3079-3100. PubMed ID: 28792021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of the Regions of Interest Multivariate Curve Resolution (ROIMCR) procedure for untargeted LC-MS lipidomic analysis.
    Dalmau N; Bedia C; Tauler R
    Anal Chim Acta; 2018 Sep; 1025():80-91. PubMed ID: 29801610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of blood on liver metabolite profiling - a combined metabolomic and proteomic approach.
    Ly-Verdú S; Schaefer A; Kahle M; Groeger T; Neschen S; Arteaga-Salas JM; Ueffing M; de Angelis MH; Zimmermann R
    Biomed Chromatogr; 2014 Feb; 28(2):231-40. PubMed ID: 23934789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics.
    Marshall DD; Powers R
    Prog Nucl Magn Reson Spectrosc; 2017 May; 100():1-16. PubMed ID: 28552170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Approaches and applications of quantitative LC-MS for proteomics and activitomics.
    Cutillas PR; Timms JF
    Methods Mol Biol; 2010; 658():3-17. PubMed ID: 20839095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LC-MS-Based Metabolomics and Lipidomics Study of High-Density-Lipoprotein-Modulated Glucose Metabolism with an apoA-I Knockout Mouse Model.
    Liu J; Zhao M; Zhu Y; Wang X; Zheng L; Yin Y
    J Proteome Res; 2019 Jan; 18(1):48-56. PubMed ID: 30543107
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.